Inventiva (IVA) Stock Analysis: AI Score & Alternative Data
IVA alt-data: job postings climbing, web traffic lagging
Is Inventiva a buy right now? The alternative data says hold. This IVA stock analysis is built on the 25+ alternative data signals AltIndex tracks on Inventiva every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 59/100: a Hold. The stock trades at $2.94 with a $694M market cap.
The bullish side of the 90-day ledger: job postings up 20.0% to 6 open roles, and headcount (according to LinkedIn) up 14.0% to 130 employees. The drag: web traffic down 25.9% to 10K monthly visits. That tension is what keeps the score mid-range.
IVA’s broader alt-data profile also covers X followers (385), and sentiment (100/100). Every signal links to its own page with full history, the IVA technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on IVA is just below.
Inventiva AI Stock Analysis
Inventiva is a clinical-stage biopharmaceutical company focused on the discovery and development of orally-available small molecule therapies to treat diseases with unmet medical need. The company's core strategy encompasses extensive in-house drug discovery expertise coupled with robust clinical development programs.
Analysis generated October 1, 2026.
Recent Inventiva Stock Alerts
|
Inventiva | October 15 Price is up by 7% in the last 24h. |
|
Inventiva | October 13 Price is down by -6.3% in the last 24h. |
|
Inventiva | October 8 Price is down by -6.1% in the last 24h. |
|
Inventiva | October 1 Price is down by -8.4% in the last 24h. |
Inventiva Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 10K | 25.9% | |
| Job Posts | 6 | 20.0% | |
| LinkedIn Employees | 130 | 14.0% | |
| Employee Recommend | 0 | N/A | |
| Business Outlook | 0 | N/A | |
| Sentiment | 100 | N/A | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 16 | 33.3% | |
| Stocktwits Mentions | 11 | 450.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 766 | 18.8% | |
| X Followers | 385 | 6.1% | |
| Youtube Subscribers | 17 | 6.3% |
About Inventiva (IVA)
Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidosis (MPS) and other diseases. The company is headquartered in Daix, France.
| Price | $2.94 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $694M |
| Year Range | $3 – $7 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Inventiva News
View more → |
Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key TestOctober 3 - Biztoc.com |
Inventiva Announces Preliminary Financial Results for the First Half of 2026¹July 29 - GlobeNewswire |
|
Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB WarrantsJuly 9 - GlobeNewswire |
|
Inventiva S.A. (IVA) is One of the Best Stocks Under $10 Offering More Than 50% UpsideJune 30 - Yahoo Entertainment |
|
Claret Capital Partners participates in €130m financing for InventivaJune 16 - GlobeNewswire |
See Inventiva’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for IVA, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEInventiva Earnings & Financial Performance
View all earnings →Inventiva Insider Trading Activity
View all →| No recent insider transactions on file. |
Inventiva Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Inventiva
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Sana BiotechnologySANA |
$2.27 8.3% | $680M | 34 |
 |
Adlai NortyeANL |
$11.03 8.8% | $710M | 47 |
 |
Lexicon PharmaceuticalsLXRX |
$1.52 7.9% | $676M | 29 |
 |
4D Molecular TherapeuticsFDMT |
$12.14 5.7% | $671M | 46 |
 |
Immix BiopharmaIMMX |
$7.98 8.1% | $720M | 54 |
Explore Inventiva Data
Frequently Asked Questions: Inventiva (IVA)
Inventiva has an AltIndex AI Score of 59/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
59/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Inventiva (IVA) stock is $2.94 with a market cap of $694M.
As of today, Inventiva’s PE (Price to Earnings) ratio is —.
View the latest Inventiva insider transactions to see recent buying and selling activity by company executives and directors.
Check the Inventiva congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The IVA stock price chart above shows Inventiva’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Inventiva technical analysis for RSI, moving averages, and more.
See the stocks similar to Inventiva section on this page for companies in the same industry ranked by market cap and AI Score.
